Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? LS Bhatia, NP Curzen, PC Calder, CD Byrne European heart journal 33 (10), 1190-1200, 2012 | 631 | 2012 |
Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study E Scorletti, L Bhatia, KG McCormick, GF Clough, K Nash, L Hodson, ... Hepatology 60 (4), 1211-1221, 2014 | 362 | 2014 |
Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial E Scorletti, AL West, L Bhatia, SP Hoile, KG McCormick, GC Burdge, ... Journal of hepatology 63 (6), 1476-1483, 2015 | 122 | 2015 |
Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study L Hodson, L Bhatia, E Scorletti, DE Smith, NC Jackson, ... European journal of clinical nutrition 71 (8), 973-979, 2017 | 79 | 2017 |
Nonalcoholic fatty liver disease and vascular risk LS Bhatia, NP Curzen, CD Byrne Current opinion in cardiology 27 (4), 420-428, 2012 | 75 | 2012 |
Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression L Bhatia, E Scorletti, N Curzen, GF Clough, PC Calder, CD Byrne Atherosclerosis 246, 13-20, 2016 | 71 | 2016 |
Design and rationale of the WELCOME trial: a randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non-alcoholic fatty … E Scorletti, L Bhatia, KG McCormick, GF Clough, K Nash, PC Calder, ... Contemporary clinical trials 37 (2), 301-311, 2014 | 50 | 2014 |
Clinical implications of ST-segment non-resolution after thrombolysis for myocardial infarction L Bhatia, GJ Clesham, DR Turner Journal of the Royal Society of Medicine 97 (12), 566-570, 2004 | 39 | 2004 |
Experimental determination of stress distributions in articular cartilage before and after sustained loading MA Adams, AJ Kerinv, LS Bhatia, G Chakrabarty, P Dolan Clinical Biomechanics 14 (2), 88-96, 1999 | 27 | 1999 |
There is a slight increase in incident diabetes risk with the use of statins, but benefits likely outweigh any adverse effects in those with moderate-to-high cardiovascular risk L Bhatia, CD Byrne BMJ Evidence-Based Medicine 15 (3), 84-85, 2010 | 26 | 2010 |
Parkinson’s tremor mimicking ventricular tachycardia L Bhatia, DR Turner Age and ageing 34 (4), 410-411, 2005 | 21 | 2005 |
Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease … KG McCormick, E Scorletti, L Bhatia, PC Calder, MJ Griffin, GF Clough, ... Diabetologia 58, 1916-1925, 2015 | 18 | 2015 |
Higher body fat percentage is associated with enhanced temperature perception in NAFLD: results from the randomised Wessex Evaluation of fatty Liver and Cardiovascular markers … GF Clough, KG McCormick, E Scorletti, L Bhatia, PC Calder, MJ Griffin, ... Diabetologia 59, 1422-1429, 2016 | 6 | 2016 |
Non-alcoholic fatty liver disease severity is related to increased cardiovascular risk independently of hyperglycaemia and obesity S Hudson, LS Bhatia, KG McCormick, A Bateman, K Nash, NP Curzen, ... Diabetologia 54, S110-S110, 2011 | 5 | 2011 |
Intracardiac recurrent thymoma arising from the coronary sinus L Bhatia, C Lee-Elliott, K Greaves The Canadian Journal of Cardiology 25 (6), e203, 2009 | 4 | 2009 |
Effect of intravenous heparin on serum levels of endostatin, VEGF and HGF L Bhatia, GJ Clesham, DR Turner Clinical Science 107 (4), 423-423, 2004 | 4 | 2004 |
Peripheral sensory nerve function is independently associated with microvascular function, but neither are improved by n-3 fatty acids KG McCormick, ES Scorletti, L Bhatia, PC Calder, MJ Griffin, GF Clough, ... Diabetic Medicine 32, 99-99, 2015 | 3 | 2015 |
High-dose n-3 fatty acid treatment in non-alcoholic fatty liver disease is independently associated with reduced hepatic steatosis and improved hepatic insulin sensitivity LS Bhatia, E Scorletti, F Shojaee-Moradie, M Umpleby, GF Clough, ... Diabetic Medicine 31, 53-53, 2014 | 1 | 2014 |
QTc duration is independently associated with tissue palmitoleic acid levels but is not affected by omega-3 fatty acid treatment in patients with non-alcoholic fatty liver … CE Palmer, E Scorletti, GF Clough, KG McCormick, L Bhatia, G Targher, ... DIABETIC MEDICINE 31, 2-2, 2014 | 1 | 2014 |
Corrigendum to “Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chain omega-3 fatty treatment in non … E Scorletti, L Bhatia, KG McCormick, GF Clough, K Nash, PC Calder, ... Contemporary Clinical Trials 1 (38), 156, 2014 | 1 | 2014 |